Molecular BiologybioRxivPreprint
CRlSPR/Cas9 screening revealed BlRC6-AS1/BlRC6 mediates abiraterone resistance via NHEJ pathway-dependent A20 degradation in prostate cancer
Lan Li, Xue-Ni An, Yongtong Ruan…·Xiaoming Dong
The paper identifies BIRC6-AS1/BIRC6 as a driver of abiraterone resistance in prostate cancer by stabilizing BIRC6 and promoting A20 degradation via NHEJ pathway disruption.
DOI 10.1101/2025.10.01.679907